Albemarle (ALB) Stock Forecast, Price & News

21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 2 sell ratings, 5 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" ALB shares.
View ALB analyst ratings or view top-rated stocks.

21 equities research analysts have issued 1 year price objectives for Albemarle's shares. Their ALB share price forecasts range from $155.00 to $498.00. On average, they predict the company's share price to reach $273.76 in the next twelve months. This suggests a possible upside of 61.9% from the stock's current price.
View analysts price targets for ALB or view top-rated stocks among Wall Street analysts.

Albemarle's stock was trading at $216.86 on January 1st, 2023. Since then, ALB stock has decreased by 22.0% and is now trading at $169.12.
View the best growth stocks for 2023 here.

Albemarle saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 7,690,000 shares, an increase of 18.5% from the August 15th total of 6,490,000 shares. Based on an average trading volume of 1,780,000 shares, the days-to-cover ratio is currently 4.3 days.
View Albemarle's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 1st 2023.
View our ALB earnings forecast.

Albemarle Co. (NYSE:ALB) issued its quarterly earnings results on Thursday, August, 3rd. The specialty chemicals company reported $7.33 EPS for the quarter, topping analysts' consensus estimates of $4.27 by $3.06. The specialty chemicals company earned $2.37 billion during the quarter, compared to analysts' expectations of $2.42 billion. Albemarle had a net margin of 40.55% and a trailing twelve-month return on equity of 45.88%. The company's revenue was up 60.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $3.45 EPS.
Read the conference call transcript.

Albemarle announced a quarterly dividend on Tuesday, July 18th. Investors of record on Friday, September 15th will be given a dividend of $0.40 per share on Monday, October 2nd. This represents a $1.60 dividend on an annualized basis and a yield of 0.95%. The ex-dividend date of this dividend is Thursday, September 14th.
Read our dividend analysis for ALB.

ETFs with the largest weight of Albemarle (NYSE:ALB) stock in their portfolio include Sprott Lithium Miners ETF (LITP), Global X Lithium & Battery Tech ETF (LIT), iShares Lithium Miners and Producers ETF (ILIT), First Trust NASDAQ Clean Edge Green Energy Index Fund (QCLN), VanEck Green Metals ETF (GMET), ALPS Clean Energy ETF (ACES), Optica Rare Earths & Critical Materials ETF (CRIT) and Sprott Energy Transition Materials ETF (SETM).

Albemarle (NYSE:ALB) pays an annual dividend of $1.60 per share and currently has a dividend yield of 0.92%. The company has been increasing its dividend for 30 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 4.81%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, ALB will have a dividend payout ratio of 7.45% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ALB.

Albemarle updated its FY 2023 earnings guidance on Wednesday, August, 2nd. The company provided earnings per share (EPS) guidance of $25.00-$29.50 for the period, compared to the consensus earnings per share estimate of $23.31. The company issued revenue guidance of $10.40 billion-$11.50 billion, compared to the consensus revenue estimate of $10.12 billion.

63 employees have rated Albemarle Chief Executive Officer Luther C. Kissam, IV on Glassdoor.com. Luther C. Kissam, IV has an approval rating of 75% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Albemarle investors own include Intact Financial (IFC), Constellation Software (CSU), AutoCanada (ACQ), Alimentation Couche-Tard (ATD.B), AbbVie (ABBV), Vermilion Energy (VET), NVIDIA (NVDA), Rogers Communications (RCI) and Alibaba Group (BABA).

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Albemarle's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (8.66%), Bank Julius Baer & Co. Ltd Zurich (6.89%), State Street Corp (4.47%), Capital Research Global Investors (2.88%), Franklin Resources Inc. (2.67%) and Baillie Gifford & Co. (2.13%). Insiders that own company stock include Eric Norris, J Kent Masters, John Clarence Barichivich III, Karen G Narwold, Karen G Narwold, Kristin M Coleman, Luther C Iv Kissam, Netha N Johnson, Raphael Goszcz Crawford and Scott Tozier.
View institutional ownership trends.

Shares of ALB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ALB stock can currently be purchased for approximately $169.12.

Albemarle (NYSE:ALB) has a market capitalization of $19.85 billion and generates $7.32 billion in revenue each year. The specialty chemicals company earns $2.69 billion in net income (profit) each year or $33.24 on an earnings per share basis.

The company employs 7,400 workers across the globe.

Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The official website for the company is www.albemarle.com. The specialty chemicals company can be reached via phone at (980) 299-5700, via email at invest@albemarle.com, or via fax at 225-388-7686.